|
|
- 2017
Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitisKeywords: 0.003% suspension, allergy, calcineurin inhibitor, tacrolimus, vernal keratoconjunctivitis Abstract: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC)
|
